TORNTPHARM.NS Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2026	2025	Change %
Total Revenue	137.529.900.000	113.172.500.000	21.5%
Cost of Revenue	35.251.100.000	28.844.900.000	22.2%
Gross Profit	102.278.800.000	84.327.600.000	21.3%
	67.881.200.000	55.067.000.000	23.3%
Operating Income	34.397.600.000	29.260.600.000	17.6%
Pretax Income	28.721.900.000	26.728.100.000	7.5%
Net Income Common Stockholders	21.633.700.000	19.112.500.000	13.2%
	--	--	--
	--	--	--